Anuncio
Anuncio
MRKR
Marker Therapeutics, Inc. Common Stock
2.01
USDPatrocinado
-0.06
-2.80%
09 ene, 15:59 UTC -5
Cerrado
Post-mercado
2.04
+0.03
+1.64%
Informes de beneficios de MRKR
Ratio de Sorpresa Positivo
MRKR superó 18 de las últimas 26 estimaciones.
69%
Próximo informe
Fecha del próximo informe
30 mar 2026
Estimate for Q4 25 (Revenue/ EPS)
$695.64K
/-$0.20
Cambio implícito desde Q3 25 (Revenue/ EPS)
-43.58%
/+66.67%
Cambio implícito desde Q4 24 (Revenue/ EPS)
-69.11%
/-52.38%
Marker Therapeutics, Inc. Common Stock earnings per share and revenue
On 13 nov 2025, MRKR reported earnings of -0.12 USD per share (EPS) for Q3 25, beating the estimate of -0.45 USD, resulting in a 73.86% surprise. Revenue reached 1.23 millón, compared to an expected 737.46 mil, with a 67.20% difference. The market reacted with a +3.48% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 5 analistas forecast an EPS of -0.20 USD, with revenue projected to reach 695.64 mil USD, implying an aumentar of 66.67% EPS, and reducir of -43.58% in Revenue from the last quarter.
Preguntas frecuentes
What were Marker Therapeutics, Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Marker Therapeutics, Inc. Common Stock reported EPS of -$0.12, beating estimates by 73.86%, and revenue of $1.23M, 67.2% above expectations.
How did the market react to Marker Therapeutics, Inc. Common Stock's Q3 2025 earnings?
The stock price moved up 3.48%, changed from $0.89 before the earnings release to $0.92 the day after.
When is Marker Therapeutics, Inc. Common Stock expected to report next?
The next earning report is scheduled for 30 mar 2026.
What are the forecasts for Marker Therapeutics, Inc. Common Stock's next earnings report?
Based on 5
analistas, Marker Therapeutics, Inc. Common Stock is expected to report EPS of -$0.20 and revenue of $695.64K for Q4 2025.
Which companies are reporting earnings today?
Cheque FXEmpire's Earnings Calendar for today's list of reporting companies.
Anuncio